Claims
- 1. A compound selected from the group consisting of racemic mixtures or optically active isomers of 1,3-benzodioxins of the formula ##STR13## wherein R.sub.1 ' is selected from the group consisting of hydrogen, alkali metal, alkaline earth metal, --NH.sub.4, aluminum, non-toxic, pharmaceutically acceptable amines, alkyl of 1 to 5 carbon atoms, 2,3-dihydroxypropanyl, (2,2-dimethyl-1,3-dioxolan-4-yl)-methyl and dialkylaminolakyl with alkyls of 1 to 4 carbon atoms, R.sub.2 is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms, R.sub.3 is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and phenyl and R.sub.4 and R.sub.5 are individually selected from the group consisting of hydrogen and halogen and the non-toxic, pharmaceutically acceptable acid addition salts where R.sub.1 ' is dialkylaminoalkyl with the proviso that R.sub.2 and R.sub.3 are not simultaneously hydrogen.
- 2. A compound of claim 1 wherein R.sub.1 ' is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, alkali metal, alkaline earth metal, aluminum, --NH.sub.4 and amines.
- 3. A compound of claim 1 wherein R.sub.1 ' is selected from the group consisting of hydrogen, methyl, alkali metal, alkaline earth metal, aluminum, --NH.sub.4 and an amine, R.sub.2 is selected from the group consisting of hydrogen and methyl, R.sub.3 is selected from the group consisting of hydrogen, methyl and phenyl, R.sub.4 is hydrogen and R.sub.5 is selected from the group consisting of hydrogen and chlorine.
- 4. A compound of claim 3 wherein R.sub.2 is hydrogen and R.sub.5 is chlorine.
- 5. A compound of claim 1 selected from the group consisting of methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylate, ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and its sodium salt, 6-chloro-2,4-dimethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, 6-chloro-4-methyl-4-(3-chloro-phenyl)-[4H]-1,3-benzodioxin-2-carboxylic acid, piperidine salt of 2 racemates A and B diastereoisomers of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, d and 1 isomers of two racemate A and B diastereoisomers of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and racemic and optically active forms of (2,2-dimethyl-1,3-dioxolan-4-yl)-methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, 2,3-dihydroxypropanyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate and 2-(diethylamino)-ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate and the non-toxic, pharmaceutically acceptable acid addition salts of the latter, 6-chloro-4,4-diphenyl-[4H]-1,3-dibenzodioxin-2-carboxylic acid and its methyl ester, 4-methyl-4-phenyl-1,3-benzodioxin-2-carboxylic acid, methyl 6-chloro-4-isopropyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-tert.-butyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-fluoro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-ethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-methyl-4-(4-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylate and methyl 7-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate.
- 6. A compound of claim 1 which is selected from the group consisting of the A isomer of methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, the A isomer of methyl 6-chloro-4-methyl-4-(3-chlorophenyl)-[4]-1,3-benzodioxin-2-carboxylate and the A isomer of ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate.
- 7. A compound of claim 1 selected from the group consisting of the A isomer of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and its sodium salt, the A isomer of 6-chloro-2,4-dimethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, the A isomer of 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylic acid and the d and l isomers of the A isomer of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid.
- 8. The A isomer of the 7-chloro-4-methyl-4-phenyl[4H]-1,3-benzodioxin-2-carboxylic acid having a RMN Spectrum (deuterochloroform, basic frequency 60 MHz): 2-hydrogen at 312 Hz and 4-CH.sub.3 at 116 Hz.
- 9. A compound of claim 1 selected from the group consisting of 2-(dimethylamino)-ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate mixtures or optically active isomers and acid addition salts thereof.
- 10. The hydrochloride of A isomer of 2-(dimethylamino)ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate having a RMN Spectrum (deuterochloroform, basic frequency 60 MHz): 2-hydrogen at 312 Hz and 4-CH.sub.3 at 115 Hz.
- 11. An hypolipemiant composition comprising an nypolipemiantly effective amount of at least one compound selected from the group consisting of racemic mixtures or optically active isomers of 1,3-benzodioxins of the formula ##STR14## wherein R.sub.1 ' is selected from the group consisting of hydrogen, alkali metal, alkaline earth metal, --NH.sub.4, aluminum, non-toxic, pharmaceutically acceptable amines, alkyl of 1 to 5 carbon atoms, 2,3-dihydroxypropanyl, (2,2-dimethyl-1,3-dioxolan-4-yl)-methyl and dialkylaminoalkyl with alkyls of 1 to 4 carbon atoms, R.sub.2 is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms, R.sub.3 is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and phenyl and R.sub.4 and R.sub.5 are individually selected from the group consisting of hydrogen and halogen and the non-toxic, pharmaceutically acceptable acid addition salts when R.sub.1 ' is dialkylaminoalkyl and an inert pharmaceutical carrier.
- 12. A composition of claim 11 wherein R.sub.1 ' is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, alkali metal, alkaline earth metal, aluminum, --NH.sub.4 and amines.
- 13. A composition of claim 11 wherein R.sub.1 ' is selected from the group consisting of hydrogen, methyl, alkali metal, alkaline earth metal, aluminum, --NH.sub.4 and an amine, R.sub.2 is selected from the group consisting of hydrogen and methyl, R.sub.3 is selected from the group consisting of hydrogen, methyl and phenyl, R.sub.4 is hydrogen and R.sub.5 is selected from the group consisting of hydrogen and chlorine.
- 14. A composition of claim 13 wherein R.sub.2 is hydrogen and R.sub.5 is chlorine.
- 15. A composition of claim 11 selected from the group consisting of methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylate, ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and its sodium salt, 6-chloro-2,4-dimethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylic acid, piperidine salts of 2 racemates A and B diastereoisomers of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, d and l isomers of two racemate A and B diastereoisomers of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and racemic and optically active forms of (2,2-dimethyl-1,3-dioxolan-4-yl) methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, 2,3-dihydroxypropanyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate and 2-(diethylamino) ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate and the non-toxic, pharmaceutically acceptable acid addition salts of the latter, 6-chloro-4,4-diphenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and its methyl ester, 4-methyl-4-phenyl-1,3-benzodioxin-2-carboxylic acid, methyl 6-chloro-4-isopropyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-tert.-butyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-fluoro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-ethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate methyl 6-chloro-4-methyl-4-(4-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylate methyl 7-chloro-4-methyl-4-phenyl-[4H]-1,e-benzodioxin-2-carboxylate, and 2-(dimethylamino) ethyle 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate and the nontoxic, pharmaceutically acceptable acid addition salts of the latter.
- 16. A composition of claim 11 selected from the group consisting of the A isomer of methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, the A isomer of methyl 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylate and the A isomer of ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate.
- 17. A composition of claim 11 selected from the group consisting of the A isomer of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and its sodium salt, the A isomer of 6-chloro-2,4-dimethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, the A isomer of 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylic acid and the d and l isomers of the A isomer of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid.
- 18. A composition of claim 11 comprising the A isomer of the 7-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid having a RMN Spectrum (deuterochloroform, basic frequency 60 MHz) 2-hydrogen at 312 Hz and 4-CH.sub.3 at 116 Hz.
- 19. A composition of claim 11 selected from the group consisting of 2-(dimethylamino)-ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, mixtures or optically active isomers and acid addition salts thereof.
- 20. A composition of claim 11 comprising the hydrochloride of A isomer of 2-(dimethylamino)-ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate having a RMN Spectrum (deuterochloroform, basic frequency 60 MHz), 2-hydrogen at 312 Hz and 4-CH.sub.3 at 115 Hz.
- 21. A method of inducing hypolipemiant activity in warm-blooded animals comprising administering a warm-blooded animals an hypolipemiantly effective amount of at least one compound selected from the group consisting of racemic mixtures or optically active isomers of 1,3-benzodioxins of the formula ##STR15## wherein R.sub.1 ' is selected from the group consisting of hydrogen, alkali metal, alkaline earth metal, --NH.sub.4, aluminum, non-toxic, pharmaceutically acceptable amines, alkyl of 1 to 5 carbon atoms, 2,3-dihydroxypropanyl, (2,2-dimethyl-1,3-dioxolan-4-yl)-methyl and dialkylaminoalkyl with alkyls of 1 to 4 carbon atoms, R.sub.2 is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms, R.sub.3 is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and phenyl and R.sub.4 and R.sub.5 are individually selected from the group consisting of hydrogen and halogen and the non-toxic, pharmaceutically acceptable acid addition salts where R.sub.1 ' is dialkylaminoalkyl.
- 22. A method of claim 21 wherein R.sub.1 ' is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, alkali metal, alkaline earth metal, aluminum, --NH.sub.4 and amines.
- 23. A method of claim 21 wherein R.sub.1 ' is selected from the group consisting of hydrogen, methyl, alkali metal, alkaline earth metal, aluminum, --NH.sub.4 and an amine, R.sub.2 is selected from the group consisting of hydrogen and methyl, R.sub.3 is selected from the group consisting of hydrogen, methyl and phenyl, R.sub.4 is hydrogen and R.sub.5 is selected from the group consisting of hydrogen and chlorine.
- 24. A method of claim 23 wherein R.sub.2 is hydrogen and R.sub.5 is chlorine.
- 25. A method of claim 21 selected from the group consisting of methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylate, ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and its sodium salt, 6-chloro-2,4-dimethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylic acid, piperidine salts of 2 racemates A and B diastereoisomers of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, d and l isomers of two racemate A and B diastereoisomers of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and racemic and optically active forms of (2,2-dimethyl-1,3-dioxolan-4-yl)-methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, 2,3-dihydroxypropanyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate and 2-(diethylamino)-ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate and the non-toxic, pharmaceutically acceptable acid addition salts of the latter, 6-chloro-4,4-diphenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and its methyl ester, 4-methyl-4-phenyl-1,3-benzodioxin-2-carboxylic acid, methyl 6-chloro-4-isopropyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-tert.-butyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-fluoro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-ethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, methyl 6-chloro-4-methyl-4-(4-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylate, methyl 7-chloro-4-methyl-4-phenyl[4H]-1,3-benzodioxin-2-carboxylate and 2-(dimethylamino)ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate and the non-toxic pharmaceutically acceptable addition salts of the latter.
- 26. A method of claim 21 selected from the group consisting of the A isomer of methyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, the A isomer of methyl 6-chloro-4-methyl-4-(3-chlorophenyl)-[4H]-1,3-benzodioxin-2-carboxylate and the A isomer of ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate.
- 27. A method of claim 21 selected from the group consisting of the A isomer of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and its sodium salt, the A isomer of 6-chloro-2,4-dimethyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid, the A isomer of 6-chloro-4-methyl-4-(3-chlorophenyl-[4H]-1,3-benzodioxin-2-carboxylic acid and the d and l isomer of the A isomer of 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylic acid.
- 28. A method of claim 21 comprising the A isomer of 7-chloro-4-methyl-4-phenyl[4H]-1,3-benzodioxin-2-carboxylic acid having a RMN Spectrum (deuterochloroform, basic frequency 60 MHz) 2-hydrogen at 312 Hz and 4-CH.sub.3 at 116 Hz.
- 29. A method of claim 21 selected from the group consisting of 2-(dimethylamino)-ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate, mixtures or optically active isomers and acid addition salts thereof.
- 30. A method of claim 21 comprising the hydrochloride of A isomer of 2-(dimethylamino)-ethyl 6-chloro-4-methyl-4-phenyl-[4H]-1,3-benzodioxin-2-carboxylate having a RMN Spectrum (deuterochloroform, basic frequency 60 MHz), 2-hydrogen at 312 Hz and 4-CH.sub.3 at 115 Hz.
Priority Claims (1)
Number |
Date |
Country |
Kind |
78 13094 |
May 1978 |
FRX |
|
PRIOR APPLICATION
This application is a continuation in part of a copending application Ser. No. 847,776 filed Nov. 2, 1977, now abandoned.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
3835159 |
Najer et al. |
Sep 1974 |
|
3836543 |
Grisar |
Sep 1974 |
|
4046762 |
Manghisi et al. |
Sep 1977 |
|
4056540 |
Buchanan et al. |
Nov 1977 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
1312893 |
Nov 1962 |
FRX |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
847776 |
Nov 1977 |
|